Direct Rx is recalling 28 bottles of Losartan Potassium/Hydrochlorothiazide (HCTZ) combination tablets, a medication used to treat high blood pressure. The recall affects three different strengths (50/12.5 mg, 100/12.5 mg, and 100/25 mg) because tests detected an impurity called AZIDO at levels exceeding safety standards. No incidents or injuries related to this recall have been reported to date. These products were packaged and distributed by Direct Rx and sold in Florida.
Long-term exposure to AZIDO impurities in blood pressure medication may pose potential health risks. Patients should not stop taking their blood pressure medication without first consulting a doctor, as the risks of untreated high blood pressure often outweigh the risks associated with this impurity.
You have 2 options:
Packaged and Distributed By: Direct Rx Dawsonville, GA 30534. Manufactured For Macleods Pharma USA, Inc. Plainsboro, NJ 08540.
Packaged and Distributed By: Direct Rx Dawsonville, GA 30534. Manufactured For Macleods Pharma USA, Inc. Plainsboro, NJ 08540.
Packaged and Distributed By: Direct Rx Dawsonville, GA 30534. Manufactured For Macleods Pharma USA, Inc. Plainsboro, NJ 08540.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.